人福医药(600079.SH)：HW231019片进入II期临床试验研究

Core Viewpoint - The company announced that its subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., has registered the Phase II clinical trial information for HW231019 tablets, focusing on postoperative pain management and safety [1] Group 1: Clinical Trial Information - The Phase II clinical trial aims to explore the efficacy and safety of HW231019 tablets for pain relief after abdominal surgery [1] - The trial will also preliminarily investigate the dosage and administration of HW231019 tablets for postoperative pain management [1]